Clinical Trial with Ethyl-α-p-Chlorophenoxyisobutyrate (Atromid-S) with Special Reference to White Blood Cell Counts
- 24 April 2009
- journal article
- research article
- Published by Wiley in Acta Medica Scandinavica
- Vol. 180 (5) , 519-532
- https://doi.org/10.1111/j.0954-6820.1966.tb02865.x
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Automated determination of serum total cholesterolClinica Chimica Acta; International Journal of Clinical Chemistry, 1964
- Further observations on the effects of atromid and of ethyl chlorophenoxyisobutyrate on serum lipid levelsJournal of Atherosclerosis Research, 1963
- The response of hyperlipoproteinemias to atromid and ethyl chlorophenoxyisobutyrateJournal of Atherosclerosis Research, 1963
- Studies on low-density lipoprotein turnover in relation to atromid therapyJournal of Atherosclerosis Research, 1963
- Agranulocytosis During Administration of "Atromid"BMJ, 1963
- EFFECT OF ATROMID AND ETHYL CHLOROPHENOXYISOBUTYRATE ON ANTICOAGULANT REQUIREMENTSThe Lancet, 1963
- EXPERIMENTAL EVALUATION OF AN ORALLY ACTIVE COMBINATION OF ANDROSTERONE WITH ETHYL CHLOROPHENOXYISOBUTYRATEThe Lancet, 1962
- REDUCTION OF SERUM-LIPID AND URIC-ACID LEVELS BY AN ORALLY ACTIVE ANDROSTERONEPublished by Elsevier ,1962
- TRANSAMINASE ACTIVITY IN HUMAN BLOODJournal of Clinical Investigation, 1955
- The Control of Dicumarol Therapy and the Quantitative Determination of Prothrombin and ProconvertinScandinavian Journal of Clinical and Laboratory Investigation, 1951